Experimental immune boost tested after cancer transplants
NCT ID NCT07285668
Summary
This early-phase study is testing whether a modified immune cell infusion given after a stem cell transplant can help prevent cancer recurrence in high-risk blood cancer patients. Researchers will give 38 participants processed immune cells from their donors to find the safest dose. The main goal is to check for side effects while seeing if this approach helps the body fight cancer without causing harmful immune reactions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOLOGIC MALIGNANCIES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
UW Carbone Cancer Center
RECRUITINGMadison, Wisconsin, 53792, United States
Conditions
Explore the condition pages connected to this study.